# X4 Pharmaceuticals, Inc: Form 8-K, filed Jun 27, 2024

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 08:01 ET
- Period: 2024-06-27
- Accession: 0001628280-24-030243
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024030243/xfor-20240627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000162828024030243/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000162828024030243/xfor-20240627.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-030243. Last ingested by Listed: Oct 29, 2026, 10:01 ET. No prices; not investment advice.